Evaluation of the clinical effect of white herb injection and combined chemotherapy for advanced malignant tumors
白花蛇舌草注射液联合化疗治疗晚期恶性肿瘤临床效果评价

摘要

目的 实验将针对晚期恶性肿瘤患者实施治疗，重点分析白花蛇舌草注射液联合化疗治疗方案的应用优势，提升临床治疗疗效。方法 针对就诊时间为2017年5月—2022年5月的晚期恶性肿瘤患者为调研对象，共计3806例，从中随机抽取300人为调研对象，可以通过1:1的方式进行平均数分组，对照组为化疗治疗，观察组为白花蛇舌草注射液联合化疗治疗，对比治疗成果。结果 从数据可见，观察组患者治疗疗效高于对照组，具有统计学意义（P＜0.05）。同时，在KPS评分上，观察组高于对照组，差异显著（P＜0.05）。此外，在症状自评量表SCL-90评分中，观察组干预后的各项评分均低于对照组，差异显著（P＜0.05）。最后，在毒副反应对比中，两组患者均不严重，且对比差异不大（P＞0.05）。结论 采用白花蛇舌草注射液联合化疗治疗对于晚期恶性肿瘤患者，有助于提升化疗治疗水平，提升KPS评分，在毒副反应上也进行了控制，故值得推广。

Abstract

Objective The experiment will be aimed at patients with advanced malignant tumors, focusing on the application advantages of the injection combined with chemotherapy, and improve the clinical treatment effect. Method: for treatment time in May 2017-May 2022 patients with advanced malignant tumor as the research object, a total of 3806 cases, randomly selected 300 people research object, can be averaged by 1:1 grouping, control group for chemotherapy treatment, observation group for white herb injection combined chemotherapy treatment, contrast treatment results.
Results: According to the data, the treatment efficacy of the patients in the observation group was higher than that of the control group, and it was statistically significant (P <0.05). Meanwhile, in the KPS score, the observation group was higher than the control group, with a significant difference (P <0.05). In addition, in the symptom self-assessment scale SCL-90 score, the observed group had lower scores after the intervention than the control group, with significant differences (P <0.05). Finally, in the toxic reaction comparison, neither group was severe and the difference was significant (P> 0.05).
Conclusion  : For patients with advanced malignancy, it can help to improve the level of chemotherapy treatment, improve the KPS score, and combine it with chemotherapy, and control the toxic side reaction, so it is worth popularizing.